ACQUISITION OF CORE ONCOLOGY'S PROSTATE BRACHYTHERAPY CUSTOMER BASE (Detail Textuals 1) (Core Oncologys, USD $)	Dec. 31, 2011
Core Oncologys
Acquired Assets [Line Items]
Accounts receivable	$ 2,200,000
Current deferred tax asset	$ 800,000